The Cooper Companies, Inc. COO
55.38
0.00
0.00%
as of 25 Sep
- Market cap
- $10.5B
- P/E
- 18.9×
Follow COO
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
The Cooper Companies, Inc. (COO) EV/Sales
As of 25 September 2026, The Cooper Companies, Inc. (COO) trades at a EV/Sales of 3.1×. Over the past ten years it has ranged from 3.0× (September 2026) to 8.9× (April 2021); the current reading is higher than 0% of that period. That is in line with the Medical Instruments & Supplies industry median of 3.1× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 4.0× | (33.34%) |
| FY2024 | 6.0× | 20.24% |
| FY2023 | 5.0× | 2.10% |
| FY2022 | 4.9× | (35.71%) |
| FY2021 | 7.6× | 5.77% |
| FY2020 | 7.2× | 17.97% |
| FY2019 | 6.1× | 5.14% |
| FY2018 | 5.8× | (3.74%) |
| FY2017 | 6.0× | 20.77% |
| FY2016 | 5.0× | 1.01% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jul 2026 | 3.9× | 11.91% |
| Apr 2026 | 3.4× | (21.21%) |
| Jan 2026 | 4.4× | 9.76% |
| Oct 2025 | 4.0× | (1.91%) |
| 43 more quarters | Free account |
Against its own ten years
Low 3.0×
High 8.9×
Ten-year median
5.8×
Current reading's percentile
0
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BAX Baxter International Inc. compare | 1.7× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| AVTR Avantor, Inc. compare | 2.1× |
| ALGN Align Technology, Inc. compare | 2.3× |
| ATR AptarGroup, Inc. compare | 2.3× |
| SOLV Solventum Corporation compare | 2.4× |
| COO The Cooper Companies, Inc. | 3.1× |
| STVN Stevanato Group S.p.A. compare | 4.3× |
| RGEN Repligen Corporation compare | 13.4× |
| Medical Instruments & Supplies industry median | 3.1× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on COO
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement